3,9-Dihydroxy-8-methyl-1,5-dihydro-[1,3,2]dioxaphosphepino[5,6-c]pyridine 3-oxide

Catalog No. :
ACLYBV574
CAS No. :
14141-47-0
Molecular Formula :
C8H10NO5P
Molecular Weight :
231.14

IUPAC Name:3,9-dihydroxy-8-methyl-1,5-dihydro-[1,3,2]dioxaphosphepino[5,6-c]pyridine 3-oxide

3,9-Dihydroxy-8-methyl-1,5-dihydro-[1,3,2]dioxaphosphepino[5,6-c]pyridine 3-oxide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3,9-Dihydroxy-8-methyl-1,5-dihydro-[1,3,2]dioxaphosphepino[5,6-c]pyridine 3-oxide
IUPAC Name3,9-dihydroxy-8-methyl-1,5-dihydro-[1,3,2]dioxaphosphepino[5,6-c]pyridine 3-oxide
MDL No.MFCD06798359
Molecular FormulaC8H10NO5P
Molecular Weight231.14
SMILESO=P1(OCC2=CN=C(C)C(O)=C2CO1)O
InChI KeyKCAJHODRYGNBSX-UHFFFAOYSA-N
SynonymMRS 2219;1,5-DIHYDRO-3-HYDROXY-8-METHYL[1,3,2]DIOXAPHOSPHEPINO[5,6-C]PYRIDIN-9-OL-3-OXIDE;1,5-Dihydro-3,9-dihydroxy-8-methyl[1,3,2]dioxaphosphepino[5,6-c]pyridin-3-one;Pyridoxine 4',5'-phosphoric acid;[1,3,2]Dioxaphosphepino[5,6-c]pyridin-9-ol, 1,5-dihydro-3-hydroxy-8-methyl-, 3-oxide;Pyridoxine-4,5-cyclic phosphate
CAS No.14141-47-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACLYBV574 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLYBV574 route product structure diagram
    ACLYBV57414141-47-0
Inquiry

2. ACLYBV574 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLYBV574 route product structure diagram
    ACLYBV57414141-47-0
Inquiry

Comments (0)